Heart surgery fluid use under the microscope: albumin study launched

NCT ID NCT06395480

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study observes how albumin and other fluids are given to adults during heart surgery at multiple hospitals. Researchers will track usage patterns and patient outcomes to fill knowledge gaps. The goal is to improve future care for cardiac surgery patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors better understand when to use albumin during heart surgery, potentially leading to improved guidelines and patient outcomes.

What could go wrong

This is an observational study, not a treatment trial, so it won't directly test a new therapy. Results may not change practice on their own.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANTITHROMBIN III LEVELS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kingston Health Sciences Centre

    Kingston, Ontario, K7L 3N6, Canada

  • Toronto General Hospital - University Health Network

    Toronto, Ontario, M5G 2C4, Canada